142 related articles for article (PubMed ID: 34135776)
1. Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis.
Li S; Wang C; Zhang X; Su W
Front Physiol; 2021; 12():688259. PubMed ID: 34135776
[TBL] [Abstract][Full Text] [Related]
2. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.
Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609
[TBL] [Abstract][Full Text] [Related]
3. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
5. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
[TBL] [Abstract][Full Text] [Related]
6. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
7. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
8. Role of Lactoferrin in Treatment of Bile Duct Ligation-Induced Hepatic Fibrosis in Rats: Impact on Inflammation and TGF-β1/Smad2/α SMA Signaling Pathway.
Al-Najjar AH; Ayob AR; Awad AS
J Clin Exp Hepatol; 2023; 13(3):428-436. PubMed ID: 37250877
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
10. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
11. Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats.
Chen CC; Ho CY; Chaung HC; Tain YL; Hsieh CS; Kuo FY; Yang CY; Huang LT
Dig Dis Sci; 2013 Feb; 58(2):440-7. PubMed ID: 23203732
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
13. Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells.
Chen YH; Lan T; Li J; Qiu CH; Wu T; Gou HJ; Lu MQ
World J Gastroenterol; 2012 Dec; 18(48):7158-65. PubMed ID: 23326120
[TBL] [Abstract][Full Text] [Related]
14. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
Uchinami H; Seki E; Brenner DA; D'Armiento J
Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.
Wimborne HJ; Takemoto K; Woster PM; Rockey DC; Lemasters JJ; Zhong Z
Free Radic Biol Med; 2019 Dec; 145():136-145. PubMed ID: 31557514
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis.
Alatas FS; Matsuura T; Pudjiadi AH; Wijaya S; Taguchi T
Pediatr Gastroenterol Hepatol Nutr; 2020 Jul; 23(4):346-355. PubMed ID: 32704495
[TBL] [Abstract][Full Text] [Related]
18. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
19. Chromium attenuates hepatic damage in a rat model of chronic cholestasis.
Chen WY; Chen CJ; Liao JW; Mao FC
Life Sci; 2009 Apr; 84(17-18):606-14. PubMed ID: 26324991
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Lee TY; Lee KC; Chang HH
Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
